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Introduction
The term myocardial bridge means the situation when a 
portion of the coronary artery with a typical subepicardial 
trajectory is covered, over a certain length, by a myocardial 
band, being included into variants of the intramural trajec-
tory of the heart arteries [1, 2].
In patients without obstructive atherosclerotic lesions, 
in 50% of cases, the cause of myocardial ischemia is the 
myocardial bridge [3].
A myocardial bridge is a congenital anomaly, which is 
developing in a close correlation with adjacent vessels [4] 
and can cause local systolic compression of varying degrees 
of the subpontine vascular segment [5].
Of particular interest are the studies researching the in-
volvement and impact of thick myocardial bridges in the 
occurrence of acute cardiac events without associated ob-
structive coronary artery disease (MINOKA), in myocardial 
infarction caused by under the bridge or distal to the bridge 
coronary thrombosis or prolonged coronary spasm [6, 7], 
sudden death of young people caused by major physical ex-
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Abstract
Background: Of particular interest are the studies researching the correlations of myocardial bridges with hypertrophic cardiomyopathy and correlations 
of thick myocardial bridges with the development of coronary atherosclerosis in the proximal to the bridge arterial part. 
Material and methods: Assessment of the correlation between myocardial bridges, coronary atherosclerosis, and the degree of hypertrophy of the left 
ventricle was performed by retrospective analysis of 6168 coronary angiography protocols (2012-2019) and echocardiographic data from patients’ 
clinical records.
Results: Moderate systolic compression predominated, and the number of patients detected with severe under the bridge systolic coronary stenosis was 
double as in patients with nonsignificant coronary atherosclerosis. From the total number, patients with myocardial hypertrophy and myocardial bridges 
were twice less when compared with the patients with the normal myocardial thickness. The comparative research did not show any interdependence 
between the degree of vascular compression and the degree of left ventricular myocardial hypertrophy. Proximal to the bridges atherosclerosis was 
detected in 32% of cases without correlation with the force of the myocardial bridge. 
Conclusions: The study showed the absence of the correlation between the degree of arterial stenosis caused by the bridge and the degree of hypertrophy 
of the ventricular myocardium as well as the degree of proximal to the bridge atherosclerosis. Important finding was that the degree of coronary systolic 
compression is higher in patients with moderate and severe proximal to the bridge atherosclerosis.
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ertion [8], with an intact coronary arteries – especially in 
case of high-performance athletes [9]or hypertrophic car-
diomyopathy [10].
Despite of multiple hypotheses regarding pontine etio-
pathogenesis, Li J. ed. (2008) stated that the ways in which 
myocardial bridges cause clinical manifestations are still 
unknown, as well as the optimal methods of their detection 
and treatment [11].
Myocardial bridges can have an evident impact on the 
patient’s quality of life, considering the angina pectoris they 
may induce [10].
Proximal to bridge atherosclerosis [12], vasospasm [8, 
13], thrombosis [14], are important etiopathogenetic links 
of the genesis of acute coronary syndrome.
Another specific feature of the intramural trajectory 
of the large coronary arteries, which is the subject of con-
troversy, is the protective role of the myocardial bridge in 
preventing atherosclerosis of the under the bridge vascular 
segment [15].
In contrast to the subpontine antiatherogenic effect, the 
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frequency of atherosclerotic lesions in prepontontine vascu-
lar segment is increased [16].
Material and methods
Assessment of the correlation between myocardial 
bridges and the degree of hypertrophy of the left ventricular 
myocardium, correlation between myocardial bridges and 
coronary atherosclerosis was performed by retrospective 
analysis of 6168 coronary angiography protocols performed 
between 2012 and 2019 at Medpark International Hospital, 
Department of Cardiology and Interventional Cardiology.
The myocardial bridges were detected in 331 of the 6168 
evaluated reports, representing 5.3% of the total number of 
cases.
Results
 In 96.4% of cases the myocardial bridges were detected 
on the left anterior descending (LAD) artery; on the rest 
of coronary arteries, myocardial bridges were described in 
3.6% of cases: the right coronary artery – 0.6%, the circum-
flex branch – 0.3%, the diagonal branches – 1.8 %, the mar-
ginal branches – 0.6%, the posterolateral branch – 0.3%. The 
existence of several myocardial bridges in the same patient 
was detected in 1.8% of cases.
The degree of subpontine arterial systolic stenosis varied 
within 10-95%. Of the total described myocardial bridges, 
in 50% of cases, they caused an insignificant systolic com-
pression of the artery, reducing the lumen of the vessel up 
to 50% of the initial value (visually appreciated) and only in 
16% of cases the degree of compression exceeded 75%.
In patients with coronary arteries not severely affected 
by atherosclerotic pathology, insignificant systolic stenosis 
caused by myocardial bridge of the subpontine arterial seg-
ment predominated, while in the second group of research 
(patients with moderate and severe atherosclerotic lesions), 
moderate systolic compression predominated and the 
number of patients detected with severe subpontine systolic 
stenosis was double as in the first group of study (fig. 1)
Another aspect, widely discussed in the scientific litera-
ture, and thoroughly analysed, is the interdependence of the 
degree of systolic stenosis of the anterior interventricular 
branch and the degree of hypertrophy of the ventricular 
myocardium.
In this study, patients were divided into: the group of 
patients with myocardial bridges and left ventricular myo-
cardial hypertrophy, and the group with myocardial bridges 
without left ventricular myocardial hypertrophy.
From the total number, patients with myocardial hyper-
trophy and myocardial bridges were twice less when com-
pared with the patients with the normal myocardial thick-
ness.
The comparative research did not show any interdepend-
ence between the degree of vascular compression caused by 
myocardial bridge and the degree of left ventricular myo-
cardial hypertrophy excepting the category of patients with 
myocardial hypertrophy and systolic stenosis lower than 
50% (fig. 2). Thereby, in patients with myocardial hypertro-
phy, were determined 10% more cases of vascular systolic 
stenosis under 50% of the vessel lumen than in patients with 
the same degree of vascular compression but without myo-
cardial hypertrophy (fig. 3).
The analysis of the dependence between the myocardial 
bridges and proximal to the bridge coronary atherosclerotic 
lesions, showed in 32% of cases atherosclerotic plaques at 
various distances to the bridge and only in one case (0.5%) – 
atherosclerotic plaques with location immediately after the 
bridge. 
Fig. 2.  Lack of direct correlation between the degree of 
left ventricular myocardial hypertrophy and the degree of 
compression of the subpontine coronary segment in the general 
group of research
No cases with under the bridge coronary atherosclerosis 
were detected.
Fig. 1. the degree of the arterial systolic compression variation 
in the group of patients without atherosclerotic lesions and with 
moderate and severe coronary lesions
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The research did not determine the interdependence be-
tween the degree of dynamic coronary stenosis caused by 
bridge and the degree of proximal to the bridge atheroscle-
rosis (fig. 4).
Fig. 3.  the correlation between the degree of subpontine 
coronary stenosis and the degree of hypertrophy of the left 
ventricular myocardium
Fig. 4.  Lack of direct correlation between the degree of 
prepontine atherosclerotic lesion and the degree of subpontine 
systolic stenosis
Discussion
Within the performed research, no cases were detected 
with atherosclerotic lesions under the myocardial bridge. 
The obtained data is consistent with the reports published 
in the medical literature. Thus, some authors attribute to 
myocardial bridges antiatherogenic functions [17], while 
the others claim the possibility of forming, in their pres-
ence, atherosclerotic plaques under the bridge in 6.7% of 
cases [18], thus denying the antiatherosclerotic role of the 
bridges [19].
Therefore, the opinions promote the idea that the as-
sociation of the myocardial bridge with the atherosclerosis 
under the bridge is very rare [20] or that this association 
presents a major risk in the occurrence of acute myocardial 
infarction [12]. Other authors mention that if the athero-
sclerosis is detected under the myocardial bridge, its degree 
of lesion is clearly lower than the proximal to the bridge 
[21].
As to the protective antiatherosclerotic mechanisms, 
both are described, the morphological features specific to 
the subpontine endothelial layer, resistant to atherosclerotic 
lesions, and the pulsating character of the coronary vessel 
under the bridge [22]. In this aspect, the essential endothe-
lial changes were highlighted, which allowed the authors to 
assume that they play a protective role against atherosclero-
sis [23].In contrast to the subpontine antiatherogenic effect, 
in the proximal to the bridge vascular segment, the inci-
dence of atherosclerotic lesions is increased [16].
Within the performed study, the atherosclerotic lesions 
visualized on angiography in the proximal to the bridge 
arterial portion were detected in 32% of cases. However, a 
correlation between the degree of coronary systolic stenosis 
and the of plaques, and the degree of proximal to the bridge 
atherosclerotic stenosis, was not found.
The obtained results did not show a definite correlation 
between the presence of myocardial bridge and prepontine 
coronary atherosclerosis.
In the recent publications of Dr. Ishikawa, he affirms 
that myocardial bridges can be considered as risk factors for 
the development of atherosclerosis in certain segments of 
the coronary arteries, especially the proximal to the bridge 
ones, and in the genesis of myocardial infarction [9].
The incidence of prepontine stenosis is lower in this 
study than in other published data. Thus, multiple studies 
denote the predisposition, in 50% up to 90% of cases, of 
the respective segment in the formation of atherosclerotic 
plaques [24], increasing thereby the risk of acute coronary 
syndrome [25]. In this context, cases of complications of 
proximal to the bridge coronary atherosclerotic plaques by 
rupture of the fibrous capsule and acute thrombosis are re-
ported [1].
Though, no correlation was detected between the de-
gree of myocardial bridge compression and the incidence 
of atherosclerotic coronary lesions and their degree. Some 
authors used IVUS (intravascular ultrasonography) during 
the diagnostic coronary angiography and established the 
direct correlation between the degree of pontine compres-
sion of the vessel and the development of atherosclerotic 
plaque in the proximal to the bridge part of coronary artery, 
the degree of systolic compression being a more influential 
factor in the development of atherosclerotic plaque than 
the length, thickness and location of complete myocardial 
bridges [4]. Therefore, the degree of prepontine coronary 
damage can serve as an indicator of the severity of the myo-
cardial bridges and the choice of the optimal treatment tac-
tics [26].
The use of intravascular imaging methods is much more 
sensitive in detecting of minimal atherosclerotic lesions in 
the prepontine coronary segment than the conventional an-
giography used in the study.
As well as the dependence between the degree of coro-
nary artery disease and the degree of coronary systolic sten-
osis, the causes of atherosclerotic prepontine lesions remain 
unclear.Some authors assume the multifactorial influence of 
the local, proximal to the bridge action of the blood flow, of 
the parietal stress, which leads to the mechanical lesion of 
the vascular wall [1].
This mechanical factor is caused by a retrograde blood 
flow, the result of the systolic expulsion of blood column 
from the intramural portion of the vessel.
The intima lesions resulted from the meeting of retro-
grade blood flow with the anterograde one, facilitate the 
rupture of atherosclerotic plaque and the appearance of 
acute coronary syndromes [1].
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However, it is mentioned the existence of differences in 
proximal to the bridge and intramural parietal stress forces.
Thus, under the myocardial bridge the parietal stress 
is higher than in the proximal to the bridge coronary seg-
ment, leading to increased transendothelial distribution of 
lipids [1].
The mentioned effects are aggravated by the turbulent 
circulation of blood in the proximal to the bridge portion, 
at the place of meeting of the anterograde blood flow with 
the retrograde one [28].
These processes are confirmed by intracoronary studies 
by Doppler investigations [27].
A particular feature, found in the current study, is the 
predominance of moderate and severe systolic stenosis 
caused by bridges in case of proximal to the bridge athero-
sclerotic plaques that reduced the coronary lumen more 
than 50%, and the number of patients with severe subpon-
tine systolic stenosis was double compared to the group of 
patients without moderate and / or severe prepontine coro-
nary atherosclerotic lesions.
The obtained results could be explained by the intra-
coronary pressure and the lower intracoronary resistance 
in case of coronary bed severely affected by atherosclerosis 
plaques located proximal to the bridge with the reduction 
of the coronary flow proximal to the bridge and increas-
ing compressive effect of the bridge. Consequently, it could 
explain why myocardial bridges bring ischemic suffering in 
older people and not from childhood or youth. At the same 
time, this peculiarity would strengthen the idea of the ex-
istence of anti-compressive mechanisms at the level of ar-
teries and myocardial bridges, which could prevent arterial 
systolic stenosis, but with the progression of atherosclerosis 
of the coronary artery the effect of these mechanisms could 
be annihilated. In this case, the intracoronary pressure de-
creases because of proximal to the bridge coronary lesions 
that diminish the coronary flow.
A second explanation, hypothesis, which could explain 
the predominance of a more pronounced degree of under 
the bridge arterial compression in the group of patients 
with moderate and severe coronary atherosclerotic lesions, 
would be the medication that patients with severe ischemic 
heart disease are taking as chronic treatment, including 
nitrates, which is increasing the degree of systolic arterial 
stenosis reducing the intracoronary pressure [19].
The above-mentioned explanations resonate with the 
concepts identified in the literature, as well as the idea that 
nitrates could accentuate the degree of systolic stenosis of 
the under the bridge vascular segment by reduction the in-
tracoronary pressure [27].
Although, some authors consider that the bridge is also 
protecting the distal to the bridge vascular segment from 
atherosclerosis [28], the results of some studies denote the 
possibility of atherosclerotic lesion of this segment [29].In 
25%-30% of cases, atherosclerosis can affect the postpon-
tine portion of the vessel [30]. Within the present study, 
these kinds of lesions were detected in only one case.
Another aspect, widely discussed in the literature and 
analysed in this study, is the interdependence between the 
degree of systolic stenosis of the anterior interventricular 
branch and the degree of myocardial hypertrophy [30].
Thereby, it is mentioned that the myocardial bridges 
are more common (up to 30%) in patients with myocardial 
hypertrophy [31].
At the same time, in the literature were found discrep-
ancies regarding the influence of myocardial bridges in pa-
tients with hypertrophic cardiomyopathy and the severity 
of clinical manifestations.
According to some studies [30], the myocardial bridges 
in people with hypertrophic cardiomyopathy are worsen-
ing the clinical picture and can lead to angina pectoris, ven-
tricular tachycardia, cardiac arrest. However, according to 
other authors, there is no correlation between myocardial 
bridges, hypertrophic cardiomyopathy, and the severity of 
the clinical picture [32]. There is evidence that in patients 
with hypertrophic cardiomyopathy, the degree of compres-
sion is increased by the myocardial bridge [30]. The im-
portance of this correlation could explain why in certain 
periods of life the myocardial bridges, which are present 
from birth, could cause myocardial ischemia [30].
From the total number, patients with myocardial 
hypertrophy and myocardial bridges were twice less, in 
comparison to patients with normal myocardial thickness. 
The results contradict the literature references that myo-
cardial bridges are more common in people with myocar-
dial hypertrophy, assuming that hypertrophy increases the 
compressive effect on the vessel of the myocardial bridge. 
The comparative research did not highlight any relation-
ship between the degree of under the bridge vascular 
compression and the degree of left ventricular myocardial 
hypertrophy in the general study group, except for the cat-
egory of patients with myocardial hypertrophy and systolic 
stenosis lower than 50%.
Thus, in patients with myocardial hypertrophy, were de-
tected 10% more cases of vascular systolic stenosis below 
50% of the vessel lumen, than in patients with the same 
degree of vascular compression, but without myocardial 
hypertrophy.
It should be noted that in the performed study there 
were no patients with diagnosed hypertrophic cardiomy-
opathy. Patients from the researched group, in most cases 
had myocardial hypertrophy up to 15 mm, assessed by 
echocardiography.
This phenomenon could be explained by the fact that in 
case of hypertrophy below 15-20 mm, possibly, the myo-
cardial bridge does not always have enough force to over-
come the intracoronary pressure, opposed to the degree of 
myocardial hypertrophy encountered in hypertrophic car-
diomyopathy [33].
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Conclusions
1. Active systolic myocardial bridges, with potential to 
induce myocardial ischemia, are detected in 5.3% of pa-
tients.
2. There is no correlation between the degree of stenosis 
caused by the bridge and the degree of hypertrophy of the 
ventricular myocardium in patients without hypertrophic 
cardiomyopathy, as well as the degree of stenosis caused by 
the bridge and the degree of proximal to the bridge athero-
sclerotic stenosis.
3. Important finding was that the degree of coronary 
systolic compression is higher in patients with moderate 
and severe proximal to the bridge atherosclerosis.
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